Stopping cell migration may help block fibrosis and the spread of cancer - Bizcommunity.com
Stopping cell migration may help block fibrosis and the spread of cancer Bizcommunity.com The researchers have both uncovered a signaling pathway that promotes cell migration in certain forms of pulmonary fibrosis, a deadly lung disease, and developed a drug treatment that may block the cancer cell migration.
Pulmonary Fibrosis Foundation Launches Partnership With Inspire Online Support ... - MarketWatch (press release)
Pulmonary Fibrosis Foundation Launches Partnership With Inspire Online Support ... MarketWatch (press release) With no FDA-approved treatment or cure for pulmonary fibrosis (PF), support groups are an important aspect to providing patients and families with a forum to improve their lives while living with the disease. Providing accessibility and improving ...
Golf: Dick King still swinging despite lung disease - Worcester Telegram
Golf: Dick King still swinging despite lung disease Worcester Telegram Dick King of Worcester, who has pulmonary fibrosis, follows a drive during a round Monday on Cyprian Keyes' par-3 course. (T&G Staff/RICK CINCLAIR) For Dick King, golf has become a breath of fresh air, and for him, that's saying a lot.
CBS4 - WHBF Quad Cities, IL-IA News Weather SportsSchool proposes renaming ... cbs4qc.com Entertainment News from AP By Clay LePard Merv Habenicht passed away last Wednesday after a battle with pulmonary fibrosis and the school is proposing renaming its football field after the former coach. "The man's legacy will continue and naming the ...
Hypertonic saline does not reduce rate of pulmonary exacerbations in young ... - News-Medical.net
Hypertonic saline does not reduce rate of pulmonary exacerbations in young ... News-Medical.net Margaret Rosenfeld, MD, MPH, of Seattle Children's Hospital, and colleagues conducted a study to examine if hypertonic saline would reduce the rate of pulmonary exacerbations in children younger than 6 years of age with cystic fibrosis (CF).
FibroGen Expands Clinical Study Based on Preliminary Data Indicating ... - MarketWatch (press release)
FibroGen Expands Clinical Study Based on Preliminary Data Indicating ... MarketWatch (press release) HRCT assessments are made by pulmonary radiology experts who are using advanced digital imaging methods to quantify extent of and changes in lung fibrosis. Combined 6-month preliminary pulmonary function and HRCT data are available for over half of the ...
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive ... - MarketWatch (press release)
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive ... MarketWatch (press release) Dr. Bruhn takes on the role of CEO at a time when Promedior is rapidly advancing its product candidates in human clinical trials for diseases involving fibrosis, including idiopathic pulmonary fibrosis (IPF), myelofibrosis, and retinal diseases.
Pulmonary fibrosis hasn't stopped cyclist's pedals InsideHalton.com Pulmonary fibrosis hasn't stopped cyclist's pedals. Indoor cycling instructor Robyn Rourke pedals beside her student and friend Rob Alexander-Carew, who last July was diagnosed with pulmonary fibrosis, a degenerative lung disease.
What our clients and candidates are saying about us: So far, I have to say you are one of the most professional, most helpful, recruiters I have ever worked with. - Dina
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.